AffyImmune Therapeutics
Natick, US · Founded 2016 · Delaware corporation
Founders & leadership
GS
Gang SongNamed on SEC filing
MJ
Moonsoo JinNamed on SEC filing
HF
Hong Fang SongNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.9M disclosed across 1 round · 2018
▶$7.9MraisedNov 2018 · 2 investors · Other TechnologyRule 506(b)
▶$7.9MraisedNov 2018 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Gang SongExecutive Officer, Director
- Moonsoo JinExecutive Officer, Director
- Hong Fang SongDirector
- Offering amount
- $14.6M
- Amount sold
- $7.9M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AffyImmune Therapeutics raised?
- AffyImmune Therapeutics has disclosed $7.9M raised across 1 round.
- Where is AffyImmune Therapeutics headquartered?
- AffyImmune Therapeutics is headquartered in Natick, US.